Manufacturer of Controlled Substances; Notice of Registration, 70989-70990 [E6-20737]
Download as PDF
70989
Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices
Schedule
Drug
Lysergic Acid Diethylamide (7315) ...
Tetrahydrocannabinol (7370) ............
Alphamethadol (9605) .......................
Phencyclidine (7471) .........................
Ecgonine (9180) ................................
Methadone (9250) .............................
Morphine (9300) ................................
I
I
I
II
II
II
II
The company plans to manufacture
small quantities of listed controlled
substances for use in diagnostic
products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Roche Diagnostics Operations, Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Roche Diagnostics
Operations, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20697 Filed 12–6–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
sroberts on PROD1PC70 with NOTICES
Importer of Controlled Substances;
Notice of Registration
By Notice dated August 14, 2006 and
published in the Federal Register on
August 21, 2006, (71 FR 48556–48557),
Sigma Aldrich Manufacturing LLC.,
Subsidiary of Sigma Aldrich
Manufacturing Company, 3500 Dekalb
Street, St. Louis, Missouri 63118, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule I and II:
VerDate Aug<31>2005
18:18 Dec 06, 2006
Jkt 211001
Drug
Schedule
Cathinone (1235) ..........................
Methcathinone (1237) ..................
Aminorex (1585) ...........................
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4–Methylenedioxy-Nethylamphetamine (7404).
3,4–
Methylenedioxymethamphetamine (MDMA) (7405).
4–Methoxyamphetamine (7411) ...
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
N-Ethyl-1-phenylcyclohexylamine
(7455).
N-Benzylpiperazine (BZP) (7493)
Trifluoromethylphenyl) Piperazine
(7494).
Heroin (9200) ...............................
Normorphine (9313) .....................
Etonitazene (9624) .......................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Nabilone (7379) ............................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Diprenorphine (9058) ...................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Opium powdered (9639) ..............
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Sigma Aldrich Manufacturing LLC to
import the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Sigma Aldrich
Manufacturing LLC to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20742 Filed 12–6–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated July 10, 2006, and
published in the Federal Register on
July 24, 2006, (71 FR 41838–41839),
Sigma Aldrich Research BioChemicals,
Inc., 1–3 Strathmore Road, Natick,
Massachusetts 01760, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedule I and II:
Drug
Cathinone (1235) ...............
Methcathinone (1237) ........
Aminorex (1585) ................
Alpha-ethyltryptamine
(7249).
Lysergic acid diethylamide
(7315).
Tetrahydrocannabinols
(7370).
E:\FR\FM\07DEN1.SGM
07DEN1
Schedule
I
I
I
I
I
I
70990
Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices
Drug
sroberts on PROD1PC70 with NOTICES
4–Bromo–2,5–
dimethoxyampheta- mine
(7391).
4–Bromo-2,5dimethoxyphenethylamine (7392).
2,5–Dimethoxyamphetamine (7396).
3,4–
Methylenedioxyamphetamine (7400).
N-Hydroxy-3,4methylenedioxyamphetamine (7402).
3,4–Methylenedioxy-Nethylamphetamine
(7404).
3,4–Methylenedioxymethamphetamine (MDMA)
(7405).
1–[1–(2–
Thienyl)cyclohexyl]piperidine
(TCP) (7470).
1–Benzylpiperazine (BZP)
(7493).
Heroin (9200) .....................
Normorphine (9313) ..........
Amphetamine (1100) .........
Methamphetamine (1105)
Nabilone (7379) .................
1–Phenylcyclohexylamine
(7460).
Phencyclidine (7471) .........
Cocaine (9041) ..................
Codeine (9050) ..................
Diprenorphine (9058) .........
Ecgonine (9180) ................
Levomethorphan (9210) ....
Levorphanol (9220) ...........
Meperidine (9230) .............
Metazocine (9240) .............
Methadone (9250) .............
Morphine (9300) ................
Thebaine (9333) ................
Levo-alphacetylmethadol
(9648).
Carfentanil (9743) ..............
Fentanyl (9801) .................
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Schedule
I
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20737 Filed 12–6–06; 8:45 am]
I
I
I
BILLING CODE 4410–09–P
I
DEPARTMENT OF JUSTICE
I
Drug Enforcement Administration
I
Importer of Controlled Substances;
Notice of Registration
I
By Notice dated July 10, 2006, and
published in the Federal Register on
July 24, 2006, (71 FR 41839–41840),
Stepan Company, Natural Products
Department, 100 W. Hunter Avenue,
Maywood, New Jersey 07607, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of Coca
Leaves (9040), a basic class of controlled
substance listed in schedule II.
The company plans to import the
listed controlled substance for the
manufacture of bulk controlled
substances and distribution to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Stepan Company to import this basic
class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Stepan
Company to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security system, verification of
the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Sigma Aldrich Research BioChemicals,
Inc. to manufacture the listed basic
classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Sigma
Aldrich Research BioChemicals, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
VerDate Aug<31>2005
18:18 Dec 06, 2006
Jkt 211001
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20748 Filed 12–6–06; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated August 15, 2006 and
published in the Federal Register on
August 22, 2006, (71 FR 48948),
Wildlife Laboratories, Inc., 1401 Duff
Drive, Suite 400, Fort Collins, Colorado
80524, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
Etorphine Hydrochloride (9059), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance for sale to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Wildlife Laboratories, Inc. to import the
basic class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Wildlife
Laboratories, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20741 Filed 12–6–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OMB Number 1121–0309]
Agency Information Collection
Activities: Proposed Collection;
Comments Requested
ACTION: 60-Day Notice of Information
Collection Under Review: International
Terrorism Victim Expense
Reimbursement Program Application.
E:\FR\FM\07DEN1.SGM
07DEN1
Agencies
[Federal Register Volume 71, Number 235 (Thursday, December 7, 2006)]
[Notices]
[Pages 70989-70990]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20737]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated July 10, 2006, and published in the Federal
Register on July 24, 2006, (71 FR 41838-41839), Sigma Aldrich Research
BioChemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the basic classes of
controlled substances listed in schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235).......................... I
Methcathinone (1237)...................... I
Aminorex (1585)........................... I
Alpha-ethyltryptamine (7249).............. I
Lysergic acid diethylamide (7315)......... I
Tetrahydrocannabinols (7370).............. I
[[Page 70990]]
4-Bromo-2,5-dimethoxyampheta- mine (7391). I
4-Bromo-2,5-dimethoxyphenethylamine (7392) I
2,5-Dimethoxyampheta- mine (7396)......... I
3,4-Methylenedioxyamphetamine (7400)...... I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymeth- amphetamine (MDMA) I
(7405).
1-[1-(2-Thienyl)cyclohexyl]piperidine I
(TCP) (7470).
1-Benzylpiperazine (BZP) (7493)........... I
Heroin (9200)............................. I
Normorphine (9313)........................ I
Amphetamine (1100)........................ II
Methamphetamine (1105).................... II
Nabilone (7379)........................... II
1-Phenylcyclohexylamine (7460)............ II
Phencyclidine (7471)...................... II
Cocaine (9041)............................ II
Codeine (9050)............................ II
Diprenorphine (9058)...................... II
Ecgonine (9180)........................... II
Levomethorphan (9210)..................... II
Levorphanol (9220)........................ II
Meperidine (9230)......................... II
Metazocine (9240)......................... II
Methadone (9250).......................... II
Morphine (9300)........................... II
Thebaine (9333)........................... II
Levo-alphacetylmethadol (9648)............ II
Carfentanil (9743)........................ II
Fentanyl (9801)........................... II
------------------------------------------------------------------------
The company plans to manufacture reference standards.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Sigma Aldrich Research BioChemicals, Inc. to manufacture the listed
basic classes of controlled substances is consistent with the public
interest at this time. DEA has investigated Sigma Aldrich Research
BioChemicals, Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with State and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above
named company is granted registration as a bulk manufacturer of the
basic classes of controlled substances listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-20737 Filed 12-6-06; 8:45 am]
BILLING CODE 4410-09-P